Item 7.01 Regulation FD Disclosure.
On January 10, 2022, Cabaletta Bio, Inc. (the “Company”) posted to the
“Investors & Media” section of the Company’s website at http://www.cabalettabio.com an
updated corporate presentation providing a corporate overview and updated
development plan (the “Corporate Presentation”). A copy of the Corporate
Presentation is attached hereto as Exhibit 99.1 and is incorporated by reference
into this Item 7.01 of this Current Report on Form 8-K.
The information contained in Item 7.01 of this Current Report on Form 8-K,
including Exhibit 99.1 attached hereto, is being furnished and shall not be
deemed to be “filed” for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section and shall not be incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Cabaletta Bio, Inc. Corporate Presentation, dated January 10, 2022,
furnished herewith.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
——————————————————————————–
© Edgar Online, source Glimpses
postbrexitcompliance.com 